Effect of neridronate in osteopenic patients after heart, liver or lung transplant: a multicenter, randomized, double-blind, placebo-controlled study-Reference-Cited by-同舟云学术

Effect of neridronate in osteopenic patients after heart, liver or lung transplant: a multicenter, randomized, double-blind, placebo-controlled study

Published:2021-06 Issue:2 Volume:63 Page:
ISSN:0031-0808
Container-title:Panminerva Medica
language:
Short-container-title:Panminerva Med

Author:

GIANNINI Sandro,POCI Carlo,FUSARO Maria,EGAN Colin G.,MARCOCCI Claudio,VIGNALI Edda,CETANI Filomena,NANNIPIERI Fabrizio,LOY Monica,GAMBINO Antonio,ADAMI Giovanni,BRAGA Vania,ROSSINI Maurizio,ARCIDIACONO Gaetano,BAFFA Valeria,SELLA Stefania

Publisher

Edizioni Minerva Medica

Subject

General Medicine

Link

https://www.minervamedica.it/pdf.php?cod=R41Y2021N02A0214

Reference44 articles.

1. Approach to the Patient with Transplantation-Related Bone Loss

2. Metabolic bone disease after renal transplantation

3. No Association Between BMD and Prevalent Vertebral Fractures in Liver Transplant Recipients at Time of Screening Before Transplantation

4. Immunosuppressant-Related Hip Pain After Orthotopic Liver Transplant

5. Impaired Bone Geometry After Heart and Heart-Lung Transplantation in Childhood

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Chronic obstructive pulmonary disease and modern therapies;Gazzetta Medica Italiana Archivio per le Scienze Mediche;2023-11

2. The role of neridronate in the management of osteoporosis: A meta-analysis;Advances in Clinical and Experimental Medicine;2023-05-30

3. Bone Disease in Long-Term Lung Transplant Survivors;Life;2023-04-01

4. Main factors influencing long-term outcomes of liver transplantation in 2022;World Journal of Hepatology;2023-03-27

5. The Rationale for Using Neridronate in Musculoskeletal Disorders: From Metabolic Bone Diseases to Musculoskeletal Pain;International Journal of Molecular Sciences;2022-06-22